• Join Today!

Become a member and connect with:

  • An Active Online Community
  • Articles and Advice on SCD
  • Help Understanding Clinical Trials

Carlton D. Dampier, MD

Department of Pediatrics
Emory University School of Medicine
2015 Uppergate Dr NE
Atlanta, Georgia, United States

Dr. Carlton Dampier is a pediatric hematologist-oncologist in Atlanta, Georgia and is affiliated with multiple hospitals in the area, including Children’s Healthcare of Atlanta and Grady Memorial Hospital. He received his medical degree from University of Chicago Pritzker School of Medicine and has been in practice for more than 20 years. His broad research interest is the assessment of patient-reported outcomes and subsequent symptom management in children and adolescents, particularly those with pain from sickle cell disease. He has led or participated in a number of studies validating specific assessment tools, as well as longitudinal observation studies examining symptom frequency by self-report or parent-proxy reporting. He has led or participated in a number of clinical trials of analgesics or investigational drugs for the treatment of vaso-occlusive sickle cell pain. As a research administrator, he has a broad interest in process improvement and quality management of clinical trials, as well as research ethics and scientific integrity in the conduct of clinical trials.


Representative Publications:

IMPROVE trial: a randomized controlled trial of patient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recommendations for future studies

Opioid patient controlled analgesia use during the initial experience with the IMPROVE PCA trial: a phase III analgesic trial for hospitalized sickle cell patients with painful episodes

Red blood cell alloimmunization in sickle cell disease: prevalence in 2010

Tissue factor-positive monocytes in children with sickle cell disease: correlation with biomarkers of haemolysis

Inpatient management of sickle cell pain: a ‘snapshot’ of current practice

Definitions of the phenotypic manifestations of sickle cell disease

expertly curated content related to this topic

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.